MASIMO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 135.9 USD | -0.75% |
|
-0.51% | +15.96% |
Financials (USD)
| Sales 2024 * | 2.1B | Sales 2025 * | 2.23B | Capitalization | 7.19B |
|---|---|---|---|---|---|
| Net income 2024 * | 109M | Net income 2025 * | 163M | EV / Sales 2024 * | 2.47 x |
| Net cash position 2024 * | 2B | Net cash position 2025 * | 1.74B | EV / Sales 2025 * | 2.45 x |
| P/E ratio 2024 * |
68.1
x | P/E ratio 2025 * |
46.6
x | Employees | 3,800 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.44% |
More Fundamentals
* Assessed data
More news
Latest transcript on Masimo Corporation
More recommendations
More press releases
More news
| 1 day | -0.75% | ||
| 1 week | -0.51% | ||
| Current month | -7.44% | ||
| 1 month | +0.73% | ||
| 3 months | +11.05% | ||
| 6 months | +68.76% | ||
| Current year | +15.96% |
1 week
131.23
138.18
1 month
131.23147.89
Current year
107.57153.93
1 year
75.22191.00
3 years
75.22305.21
5 years
75.22305.21
10 years
19.30305.21
| Managers | Title | Age | Since |
|---|---|---|---|
Joe Kiani
CEO | Chief Executive Officer | 59 | 89-04-30 |
Micah Young
DFI | Director of Finance/CFO | 45 | 17-10-15 |
Bilal Muhsin
COO | Chief Operating Officer | 43 | 99-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rolf Classon
BRD | Director/Board Member | 79 | Nov. 02 |
Craig Reynolds
BRD | Director/Board Member | 75 | 14-04-02 |
Joe Kiani
CEO | Chief Executive Officer | 59 | 89-04-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.81% | 2 M€ | +5.19% | ||
| 0.45% | 8 M€ | -.--% | ||
| 0.41% | 18 M€ | +3.04% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 135.9 | -0.75% | 234,381 |
| 24-04-23 | 137 | +1.96% | 317,033 |
| 24-04-22 | 134.3 | -0.33% | 201,190 |
| 24-04-19 | 134.8 | -0.85% | 353,006 |
| 24-04-18 | 135.9 | -0.51% | 238,494 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotes
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.
Calendar
2024-05-07
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
135.9
USD
Average target price
150.6
USD
Spread / Average Target
+10.80%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.96% | 7.19B | |
| +72.58% | 12.34B | |
| -18.04% | 7.98B | |
| +3.57% | 5.81B | |
| +6.65% | 5.04B | |
| +20.83% | 4.31B | |
| -20.27% | 4.03B | |
| -41.19% | 2.21B | |
| +0.25% | 1.99B | |
| +4.02% | 1.87B |
- Stock Market
- Equities
- MASI Stock
